Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2000
08/23/2000EP1029851A1 Piperazine compounds and medicinal use thereof
08/23/2000EP1028960A1 Process for the preparation of thiazolidinedione derivatives
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028949A1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028730A1 Compositions of lipid lowering agents
08/23/2000CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1055691C 3-alkylcarbonyl-thiadiazinenone
08/23/2000CN1055686C Substituted benzisoxazole and benzisothaazole herbicidal agents
08/22/2000US6107329 Hypotensive agents; cardiovascular disorders
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107317 N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
08/22/2000US6107312 Bactericide
08/22/2000US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/22/2000US6107308 Antihistamine; leutriene antagonist
08/22/2000US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
08/22/2000US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
08/22/2000US6107295 Arylalkanoyl pyridazines
08/22/2000US6107251 Oxazole derivative, process for producing the same, and herbicide
08/22/2000US6107024 Using 1,2-dioxetane derivative substrate in enzyme-linked assay where enzyme is linked to antigen, antibody, hapten or nucleic acid; forms aryloxide intermediate when triggered, then releases energy to form light and two carbonyl compounds
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2085987C Piperidyl-substituted indoles
08/17/2000WO2000047584A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000WO2000047579A1 Substituted benzthiazolylalkylamino-1,3,5-triazines as herbicides
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047568A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000DE19907480A1 New epothilone derivatives, useful for treating malignant tumors such as ovarian, stomach, colon, breast and lung carcinoma, acute lymphocytic and myelocytic leukemia and chronic inflammatory diseases such as psoriasis
08/17/2000DE19905609A1 Substituierte Benzthiazolylalkylamino-1,3,5-triazine Benzthiazolylalkylamino substituted-1,3,5-triazines
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362147A1 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000CA2360952A1 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000CA2360305A1 Lactam inhibitors of fxa and method
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/16/2000EP1027347A2 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
08/16/2000EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027052A1 Novel combination
08/16/2000EP1027051A1 Antithrombotic agents
08/16/2000EP0815093B1 Herbicide fluorothiadiazolyl oxyacetamides
08/16/2000CN1055465C Optical active 2-imidazoline-5-thione derivatives and preparating method and use thereof
08/16/2000CN1055461C Aryl acetic acid derivatives and use as germicide
08/15/2000US6103910 D-proline derivatives
08/15/2000US6103718 Selective cyclic nucleotide phosphodiesterase (pde) inhibitors (specifically of type 4) which are effective bronchial therapeutics; bronchodilators; respiratory system disorders
08/15/2000US6103715 Compounds that bind to the dopamine d4 receptor and their use as anxiolytic agents, treatment for schizophrenia, and drug screening; side effect reductioon
08/15/2000CA2196215C 1,4-dihydropyridine compound and pharmaceutical composition containing the same
08/15/2000CA2136553C 7-(2-aminoethyl)-benzothiazolones
08/15/2000CA2105385C Treatment of cognitive disorders
08/15/2000CA2046883C Heterocyclic derivatives, method for preparing same, and their therapeutic applications
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046199A2 Indole derivatives as anti-inflammation agents
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000045635A1 Thiazole derivatives and combinatorial libraries thereof
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19905256A1 New heteroaromatic compounds, useful e.g. in the treatment of Parkinson's, Alzheimer's and Huntington's diseases, stimulate neurite growth
08/10/2000CA2362259A1 Antizyme modulators and their use
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2355734A1 Indole derivatives as anti-inflammation agents
08/09/2000EP1026162A1 Antirheumatic
08/09/2000EP1025088A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease
08/09/2000EP0823068B1 Color-providing compounds
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands
08/09/2000CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262272A HIV proteinase inhibitor
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100403 Production of benzaldehyde compounds
08/08/2000US6100402 Pyridyl-1,2,4-thiadiazoles
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100268 Vasoconstrictive dihydrobenzopyran derivatives
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100258 Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
08/08/2000US6100257 2-haloalkyl,3-(haloalkyl, alkenyl, or alkynyl),5-(substituted phenyl or heterocycle),6-alkyl-pyrimidin-4-one compounds of given structure; use as herbicides
08/08/2000US6100255 Bind selectively with high affinity to the dopamine d4 receptor subtype; use in treating various neuropsychological disorders, including alzheimer's disease, schizophrenia, parkinson's disease, or tardive dyskinesia
08/08/2000US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases
08/08/2000US6100238 Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
08/08/2000US6100220 Pesticides and herbicides
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/03/2000WO2000044743A1 Amide derivatives and drug compositions
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents
08/03/2000WO2000044726A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
08/03/2000WO2000044468A1 Sonic impinging jet crystallization apparatus and process
08/03/2000WO2000044376A1 Antidepressant heterocyclic compounds
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000DE19904310A1 Verfahren zur Herstellung heterocyclischer Verbindungen Process for the preparation of heterocyclic compounds
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361078A1 Sonic impinging jet crystallization apparatus and process
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 628